Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Que

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 10, 2024
Targeting KIFC1 Promotes Senescence in Soft Tissue Sarcoma via FXR1-Dependent Regulation of MAD2L1 mRNA StabilityXiu-Xia Lu, Yi Que, Jing Yang, et al.
Eclinicalmedicine|July 15, 2024
Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I studySuying Lu, Juan Wang, Junting Huang, et al.
Pharmacogenomics and Personalized Medicine|April 1, 2021
Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT RegimenXiaoqin Zhu, Jia Zhu, Feifei Sun, et al.
Aging|February 15, 2021
Identification of prognostic immune-related genes in rhabdoid tumor of kidney based on TARGET database analysisHuimou Chen, Suying Lu, Jinqiu Guan, et al.
Frontiers in Immunology|June 23, 2025
Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in ChinaLei Mao, Mengzhen Li, Linnan Wu, et al.
Cell Death & Disease|June 16, 2021
ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastomaMengzhen Li, Chengtao Sun, Xiaoyun Bu, et al.
Cell Death & Disease|February 9, 2024
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastomaJinqiu Guan, Mengzhen Li, Yi Wang, et al.
Oncogene|September 19, 2024
SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesisMengzhen Li, Feifei Sun, Juan Wang, et al.
JCI Insight|February 10, 2025
AURKB inhibition induces rhabdomyosarcoma apoptosis and ferroptosis through NPM1/SP1/ACSL5 axisHuimou Chen, Mengzhen Li, Yu Zhang, et al.
Frontiers in Pharmacology|April 18, 2022
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid TumorsSuying Lu, Ye Hong, Huimou Chen, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 10, 2024
Targeting KIFC1 Promotes Senescence in Soft Tissue Sarcoma via FXR1-Dependent Regulation of MAD2L1 mRNA StabilityXiu-Xia Lu, Yi Que, Jing Yang, et al.
Eclinicalmedicine|July 15, 2024
Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I studySuying Lu, Juan Wang, Junting Huang, et al.
Pharmacogenomics and Personalized Medicine|April 1, 2021
Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT RegimenXiaoqin Zhu, Jia Zhu, Feifei Sun, et al.
Aging|February 15, 2021
Identification of prognostic immune-related genes in rhabdoid tumor of kidney based on TARGET database analysisHuimou Chen, Suying Lu, Jinqiu Guan, et al.
Frontiers in Immunology|June 23, 2025
Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in ChinaLei Mao, Mengzhen Li, Linnan Wu, et al.
Cell Death & Disease|June 16, 2021
ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastomaMengzhen Li, Chengtao Sun, Xiaoyun Bu, et al.
Cell Death & Disease|February 9, 2024
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastomaJinqiu Guan, Mengzhen Li, Yi Wang, et al.
Oncogene|September 19, 2024
SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesisMengzhen Li, Feifei Sun, Juan Wang, et al.
JCI Insight|February 10, 2025
AURKB inhibition induces rhabdomyosarcoma apoptosis and ferroptosis through NPM1/SP1/ACSL5 axisHuimou Chen, Mengzhen Li, Yu Zhang, et al.
Frontiers in Pharmacology|April 18, 2022
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid TumorsSuying Lu, Ye Hong, Huimou Chen, et al.
Pageof 6